Lou Gehrig's disease is a devastating condition in which motor neuron degeneration causes progressive loss of movement and muscle tone, leading to death.
Throughout ALS Awareness Month, The Association and its nationwide network of more than 100 affiliates reached out to communities across the country to educate the public about
Lou Gehrig's Disease and urge them to join the fight to make ALS a disease of the past.
ALSA's new mission statement is: "To lead the fight to cure and treat ALS through global cutting-edge research, and to empower people with
Lou Gehrig's disease and their families to live fuller lives by providing them with compassionate care and support."
Memorial contributions may be made to House of Peace and Education, Inc., 20 Waterford St., Gardner, MA 01440 or to the Amyotrophic Lateral Sclerosis Society of America, (
Lou Gehrig's Disease), 15300 Ventura Blvd., Suite 315, Sherman Oaks, CA 91403.
Both research teams report data hinting that this protein may protect motor neurons, the nerve cells attacked by amyotrophic lateral sclerosis (ALS), or
Lou Gehrig's disease. People with ALS experience progressive weakness of the muscles in the hands, forearms, and legs as their motor neurons disintegrate.
Researchers know that apoptosis, the orderly death of a cell that takes place during development, occurs in
Lou Gehrig's disease (SN: 3/26/94, p.203).
Earlier this month, an international research team reported that an experimental drug slowed the deadly progression of
Lou Gehrig's disease, an incurable neuromuscular disease that cripples and kills its victims.
Glutamate and inept superoxide dismutase may both figure into a chemical conspiracy, These substances help create a molecular cabal that leads to nerve destruction not only in
Lou Gehrig's disease but also in several other neurodegenerative disorders, say Stuart A.
In March, researchers announced they had pinpointed the faulty gene in the familial form of amyotrophic lateral sclerosis (ALS), often called
Lou Gehrig's disease (SN: 3/6/93, p.
Also, the alliance predicts, researchers will have gathered by decade's end the basic knowledge to develop new treatments for major afflictions, including brain and spinal cord injury, stroke, multiple sclerosis, Alzheimer's disease, epilepsy, Parkinsons disease, manic-depressive illness, anxiety disorders, drug addiction, schizophrenia, chronic pain, and amyotrophic lateral sclerosis (
Lou Gehrig's disease).
In the U.S., more than 48M people live with physical or mobility disabilities and every day about 15 people are newly diagnosed with ALS, or
Lou Gehrig's disease, a disease that attacks nerve cells in the brain and spinal cord.
He died in 1941 of a muscle-wasting disease which became known as
Lou Gehrig's Disease.